GlaxoSmithKline publishes Full-year Results on Weds, 6 Feb.

• Last time GlaxoSmithKline reported: Q3 Results, 31 Oct.
• The shares closed -1.7% for a daily range of 100.8p or 6.6%.
• Shares -10.0% from 2018 highs; +20.0% from 2018 lows; -0.5% year-to-date.
• Currently 1483p (at time of writing).
• Will we see another big share price move on Wednesday?
• Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal

Click to enlarge

Trading GlaxoSmithKline – An Example

Let’s say you think that GlaxoSmithKline results are likely to be good, and the share price is likely to rise. You decide to buy exposure to £10,000 worth of GlaxoSmithKline using CFDs, at the current price of 1483p. To do this, you need £2,000.

For the purpose of this example, let’s assume GlaxoSmithKline reports strong results and the shares rise 10%. Your profit would be £1000, from your initial investment of £2,000.

Conversely, let’s assume you open the position, and place a stop-loss 5% below the current price. GlaxoSmithKline results miss, it falls 5% and hits your stop-loss. Your loss would be £500.

This is provided for information purposes only. It should not be taken as a recommendation.